森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/28 | 1,872 | 1,872 | 1,871 | 1,871 | -1 | -0.1% | 1,300 |
| 2022/04/27 | 1,875 | 1,877 | 1,872 | 1,872 | -5 | -0.3% | 1,400 |
| 2022/04/26 | 1,875 | 1,883 | 1,875 | 1,877 | -6 | -0.3% | 500 |
| 2022/04/25 | 1,881 | 1,883 | 1,875 | 1,883 | +8 | +0.4% | 1,200 |
| 2022/04/22 | 1,875 | 1,883 | 1,875 | 1,875 | -9 | -0.5% | 900 |
| 2022/04/21 | 1,884 | 1,885 | 1,876 | 1,884 | ±0 | ±0% | 800 |
| 2022/04/20 | 1,877 | 1,884 | 1,874 | 1,884 | +7 | +0.4% | 2,000 |
| 2022/04/19 | 1,882 | 1,884 | 1,877 | 1,877 | -5 | -0.3% | 600 |
| 2022/04/18 | 1,873 | 1,882 | 1,873 | 1,882 | ±0 | ±0% | 1,200 |
| 2022/04/15 | 1,882 | 1,882 | 1,873 | 1,882 | -1 | -0.1% | 1,400 |
| 2022/04/14 | 1,880 | 1,883 | 1,880 | 1,883 | +3 | +0.2% | 500 |
| 2022/04/13 | 1,871 | 1,880 | 1,871 | 1,880 | +4 | +0.2% | 1,100 |
| 2022/04/12 | 1,875 | 1,882 | 1,874 | 1,876 | -1 | -0.1% | 800 |
| 2022/04/11 | 1,876 | 1,877 | 1,875 | 1,877 | ±0 | ±0% | 500 |
| 2022/04/08 | 1,880 | 1,885 | 1,877 | 1,877 | -8 | -0.4% | 1,200 |
| 2022/04/07 | 1,885 | 1,885 | 1,883 | 1,885 | ±0 | ±0% | 400 |
| 2022/04/06 | 1,886 | 1,891 | 1,885 | 1,885 | -1 | -0.1% | 1,100 |
| 2022/04/05 | 1,880 | 1,894 | 1,876 | 1,886 | +6 | +0.3% | 2,200 |
| 2022/04/04 | 1,885 | 1,886 | 1,876 | 1,880 | -6 | -0.3% | 1,900 |
| 2022/04/01 | 1,886 | 1,886 | 1,883 | 1,886 | ±0 | ±0% | 1,300 |
| 2022/03/31 | 1,888 | 1,892 | 1,886 | 1,886 | -7 | -0.4% | 400 |
| 2022/03/30 | 1,876 | 1,903 | 1,876 | 1,893 | -47 | -2.4% | 2,700 |
| 2022/03/29 | 1,930 | 1,944 | 1,929 | 1,940 | -3 | -0.2% | 1,600 |
| 2022/03/28 | 1,928 | 1,943 | 1,928 | 1,943 | +13 | +0.7% | 2,400 |
| 2022/03/25 | 1,925 | 1,930 | 1,924 | 1,930 | +5 | +0.3% | 1,200 |
| 2022/03/24 | 1,925 | 1,925 | 1,916 | 1,925 | -1 | -0.1% | 1,300 |
| 2022/03/23 | 1,926 | 1,926 | 1,925 | 1,926 | ±0 | ±0% | 1,600 |
| 2022/03/22 | 1,930 | 1,931 | 1,926 | 1,926 | -1 | -0.1% | 900 |
| 2022/03/18 | 1,914 | 1,927 | 1,914 | 1,927 | +13 | +0.7% | 500 |
| 2022/03/17 | 1,927 | 1,936 | 1,914 | 1,914 | -13 | -0.7% | 2,100 |
| 2022/03/16 | 1,922 | 1,928 | 1,922 | 1,927 | +2 | +0.1% | 800 |
| 2022/03/15 | 1,920 | 1,925 | 1,920 | 1,925 | +3 | +0.2% | 1,200 |
| 2022/03/14 | 1,923 | 1,923 | 1,914 | 1,922 | - | - | 400 |
| 2022/03/11 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/03/10 | 1,912 | 1,913 | 1,912 | 1,913 | +3 | +0.2% | 300 |
| 2022/03/09 | 1,913 | 1,914 | 1,904 | 1,910 | -1 | -0.1% | 2,400 |
| 2022/03/08 | 1,924 | 1,924 | 1,911 | 1,911 | -13 | -0.7% | 1,500 |
| 2022/03/07 | 1,914 | 1,924 | 1,914 | 1,924 | +4 | +0.2% | 700 |
| 2022/03/04 | 1,915 | 1,922 | 1,915 | 1,920 | -4 | -0.2% | 400 |
| 2022/03/03 | 1,915 | 1,924 | 1,910 | 1,924 | +9 | +0.5% | 1,200 |
| 2022/03/02 | 1,914 | 1,915 | 1,907 | 1,915 | +1 | +0.1% | 1,600 |
| 2022/03/01 | 1,907 | 1,914 | 1,907 | 1,914 | +1 | +0.1% | 400 |
| 2022/02/28 | 1,914 | 1,914 | 1,903 | 1,913 | -1 | -0.1% | 1,300 |
| 2022/02/25 | 1,914 | 1,914 | 1,911 | 1,914 | +11 | +0.6% | 900 |
| 2022/02/24 | 1,903 | 1,912 | 1,901 | 1,903 | -2 | -0.1% | 800 |
| 2022/02/22 | 1,906 | 1,910 | 1,905 | 1,905 | -1 | -0.1% | 900 |
| 2022/02/21 | 1,910 | 1,920 | 1,906 | 1,906 | -9 | -0.5% | 1,000 |
| 2022/02/18 | 1,912 | 1,916 | 1,910 | 1,915 | +4 | +0.2% | 800 |
| 2022/02/17 | 1,911 | 1,911 | 1,905 | 1,911 | ±0 | ±0% | 700 |
| 2022/02/16 | 1,910 | 1,911 | 1,910 | 1,911 | +3 | +0.2% | 700 |
801～
850
件表示中 / 3756件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 220,000円 | +0.3% | +9.2% | 2.95% | 12.52倍 | 0.74倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| カイオム | 14,200円 | +92.3% | - | 0.00% | - | 5.06倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| 坪田ラボ | 37,600円 | +3.2% | -21.7% | 0.00% | 64.27倍 | 6.08倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| ＯＴＳ | 2,900円 | +33.3% | - | 0.00% | - | 13.43倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ケイファーマ | 72,500円 | - | - | 0.00% | - | 3.73倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム
